The Remarkable Life of Ibelin, a documentary on Netflix, explains how a terminally ill boy found freedom in World of Warcraft ...

The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

Tommy was given a tour of the Bills facility in his hometown and met with head coach Sean McDermott as part of his ...

The co-owner, Chad Day, has been a part of the fundraising efforts for the six-year-old with Duchenne muscular dystrophy.

ABEL Motorsports driver Callum Hedge (photo) is trying to raise awareness and funds to combat muscular dystrophy in his ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Dyne Therapeutics (DYN) announced that the European Commission has granted orphan drug designation for DYNE-251 for the treatment of Duchenne ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

Duchenne muscular dystrophy (DMD) is a devastating genetic disorder affecting approximately 1 in 3,500-5,000 newborn males worldwide. It is characterized by progressive degeneration of skeletal, ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as ...

For most parents, newborn screening tests are a barely perceptible safety net. But for the small minority whose babies get ...